Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Add-on Anti-Toxoplasmosis Treatment on Parameters Defining Toxoplasma Gondii Infection and on Psychopathology in Patients With Schizophrenia or Major Depression Serologically Positive for Toxoplasma Gondii - Phase 3 Study

NCT00300404 is registered in ClinicalTrials.gov with Zentrum für Integrative Psychiatrie as lead sponsor.

NCT NCT00300404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00300404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Add-on Anti-Toxoplasmosis Treatment on Parameters Defining Toxoplasma Gondii Infection and on Psychopathology in Patients With Schizophrenia or Major Depression Serologically Positive for Toxoplasma Gondii - Phase 3 Study
Lead sponsor
Zentrum für Integrative Psychiatrie
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2002
Completion date
September 30, 2005
Enrollment
40
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depression, schizophrenia